Results for tag: "Upadacitinib"

Upadacitinib is a type of immune disorder drug used to treat a variety of conditions, including rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. It is a Janus kinase (JAK) inhibitor, meaning it works by blocking the activity of certain enzymes that are involved in the body's inflammatory response. Upadacitinib is taken orally and is available in both tablet and capsule form. It is typically prescribed in combination with other medications, such as methotrexate or corticosteroids. Upadacitinib has been shown to be effective in reducing symptoms of rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. It has also been found to be safe and well-tolerated in clinical trials. Common side effects include nausea, diarrhea, and headache. Some companies in the Upadacitinib market include AbbVie, Pfizer, and Eli Lilly. Show Less Read more